Not Yet Recruiting OBSERVATIONAL NCT06565806

French National Cohort of Patients With Rifampicin-Resistant Tuberculosis (CONTRol-TB)

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Rifampicin-resistant Tuberculosis

Updated 1 time since 2024 Last updated: Aug 19, 2024 Started: Sep 1, 2024 Primary completion: Aug 1, 2029 Completion: Sep 1, 2032

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Rifampicin-resistant Tuberculosis and is currently actively recruiting participants. Assistance Publique - Hôpitaux de Paris leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

1 version recorded

Not Yet Recruiting [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.